ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 225 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,087,000 | -70.6% | 722,569 | -59.0% | 0.84% | -53.8% |
| Q4 2019 | $17,287,000 | -12.6% | 1,761,325 | -2.2% | 1.82% | -11.9% |
| Q3 2019 | $19,769,000 | +46.6% | 1,800,453 | +55.3% | 2.06% | +55.0% |
| Q2 2019 | $13,487,000 | +5.6% | 1,159,712 | -13.4% | 1.33% | +7.7% |
| Q1 2019 | $12,768,000 | +3.9% | 1,338,415 | +29.0% | 1.24% | +1.5% |
| Q4 2018 | $12,286,000 | – | 1,037,916 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |